Armistice Capital’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-194,408
Closed -$3.4M 209
2022
Q1
$3.4M Sell
194,408
-79,349
-29% -$1.5M 0.07% 89
2021
Q4
$6.43M Buy
+273,757
New +$9.23M 0.11% 102

Other funds holding PHXM

Armistice Capital's PHXM Position: Q2 2022 in Review

Armistice Capital sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q2 2022, closing a stake of 194,408 shares — an estimated $3.4M sold.

Armistice Capital first reported a position in PHXM in Q4 2021 and held it in 2 quarters. The position peaked at $6.43M in Q4 2021. 6 funds tracked by Wall St. Rank hold PHXM as of Q2 2022.

  • Armistice Capital reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Armistice Capital sold 194,408 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q2 2022, an estimated $3.4M.
  • Armistice Capital first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2021 and held it in 2 quarters.
  • Armistice Capital's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $6.43M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q2 2022.

Based on Armistice Capital's 13F filing for Q2 2022, filed 15 Aug 2022.